Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis

NCT02534805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 232

Last updated 2025-09-09

Study results available
· View outcomes & findings →

Summary

To use the PatientBuddy App to reduce 30-day avoidable readmissions in cirrhotic patients using a patient and caregiver perspective.

Conditions

  • Cirrhosis

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED
  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Jasmohan S Bajaj, MD · VCU Medical Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02534805 on ClinicalTrials.gov